文献速递血栓与止血

癌症相关静脉血栓栓塞:种族多样化人群中的发病率与特征

Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population.
PubMed 文献 · J Thromb Haemost · 2022-08-07

该研究在俄克拉荷马县开展基于人群的前瞻性监测(2012—2014年),评估癌症相关静脉血栓栓塞(VTE)的发病率及人口学和种族差异。成人年龄调整发病率为70.0/10万人年(95%CI 65.1-75.3),不同种族间差异明显。活动性癌症患者2年内复发VTE为38/304例(12.5%),既往癌症>6个月者为34/424例(8.0%)。

要点

  • 成人癌症相关VTE年龄调整发病率为70.0/10万人年(95%CI 65.1-75.3)。
  • 非西班牙裔黑人年龄调整发病率最高,为85.9/10万人年(95%CI 72.7-101.6)。
  • 活动性癌症患者2年内复发VTE为12.5%,既往癌症>6个月者为8.0%。

核心结论

  • 癌症相关VTE的年龄调整发病率因种族和族裔不同而存在明显差异。
  • 首次VTE和复发性VTE相对较高的发病率提示需进一步评估癌症患者的VTE预防策略。

研究设计与样本

  • 基于人群的前瞻性研究,在俄克拉荷马县三级医疗机构和门诊开展VTE监测,时间为2012—2014年。
  • 监测包括审阅所有用于诊断VTE的影像报告,并从出院数据和死亡证明中识别VTE事件。
  • 癌症状态通过与俄克拉荷马中央癌症登记处链接确定。
  • 采用泊松回归计算癌症相关VTE每10万一般人群每年的粗发病率和年龄调整发病率及95%CI。

主要发现

  • 年龄≥18岁成人癌症相关VTE的年龄调整发病率为70.0/10万人年(95%CI 65.1-75.3)。
  • 非西班牙裔黑人年龄调整发病率为85.9/10万人年(95%CI 72.7-101.6),非西班牙裔白人为79.5/10万人年(95%CI 13.2-86.5),美洲原住民为18.8/10万人年(95%CI 8.9-39.4)。
  • 亚裔/太平洋岛民年龄调整发病率为15.6/10万人年(95%CI 7.0-34.8),西班牙裔为15.2/10万人年(95%CI 9.2-25.1)。
  • 活动性癌症患者初次诊断后2年内复发VTE为38/304例(12.5%),既往癌症>6个月者为34/424例(8.0%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on the population-based incidence of cancer-associated venous thromboembolism (VTE) from racially diverse populations are limited. OBJECTIVE: To evaluate the incidence and burden of cancer-associated VTE, including demographic and racial subgroups in the general population of Oklahoma County-which closely mirrors the United States. DESIGN: A population-based prospective study. SETTING: We conducted surveillance of VTE at tertiary care facilities and outpatient clinics in Oklahoma County, Oklahoma, from 2012-2014. Surveillance included reviewing all imaging reports used to diagnose VTE and identifying VTE events from hospital discharge data and death certificates. Cancer status was determined by linkage to the Oklahoma Central Cancer Registry. MEASUREMENTS: We used Poisson regression to calculate crude and age-adjusted incidence rates of cancer-associated VTE per 100 000 general population per year, with 95% confidence intervals (95% CI). RESULTS: The age-adjusted incidence (95% CI) of cancer-associated VTE among adults age ≥ 18 was 70.0 (65.1-75.3). The age-adjusted incidence rates (95% CI) were 85.9 (72.7-101.6) for non-Hispanic Blacks, 79.5 (13.2-86.5) for non-Hispanic Whites, 18.8 (8.9-39.4) for Native Americans, 15.6 (7.0-34.8) for Asian/Pacific Islanders, and 15.2 (9.2-25.1) for Hispanics. Recurrent VTE up to 2 years after the initial diagnosis occurred in 38 of 304 patients (12.5%) with active cancer and in 34 of 424 patients (8.0%) with a history of cancer > 6 months previously. CONCLUSION: Age-adjusted incidence rates of cancer-associated VTE vary substantially by race and ethnicity. The relatively high incidence rates of first VTE and of recurrence warrant further assessment of strategies to prevent VTE among cancer patients.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Raskob GE, Wendelboe AM, Campbell J, et al. Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population. J Thromb Haemost. 2022. PMID: 35830203. doi:10.1111/jth.15818

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。